Doximity, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Doximity, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Doximity, Inc. has published 203 insider filings. Market capitalisation: €4.8bn. The latest transaction was reported on 31 August 2026 (Attribution). Among the most active insiders: Wampler Kira Scherer. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate Doximity, Inc. Hold (neutral), based on 18 analysts. Average price target: US$29.78.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,922 of 29,062 companies
FCF yld 6.7%
Earn yld 4.1%
EV/EBITDA 20.8x
ROE 17%
Gross mgn 89%
Net mgn 30%
Debt/EBITDA 0.0x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
All Executives203 Thresholds0 Prospectus0 Other0
Declarations 203 total
◆ Director · Executives · 27 Aug 2026
8,084 shares 0Class A Common Stock SEC:0001470831-26-000855:0
◆ Director · Executives · 27 Aug 2026
8,084 shares 0Class A Common Stock SEC:0001470831-26-000857:0
◆ Director · Executives · 27 Aug 2026
8,084 shares 0Class A Common Stock SEC:0001193125-26-376956:0
◆ Director · Executives · 27 Aug 2026
8,084 shares 0Class A Common Stock SEC:0001470831-26-000859:0
◆ Director · Executives · 27 Aug 2026
8,084 shares 0Class A Common Stock SEC:0001470831-26-000861:0
● Director · Executives · 25 Aug 2026
2,000 shares Class A Common Stock SEC:0001862897-26-000013:0
▼ Director · Executives · 25 Aug 2026
2,000 shares @ US$24.95 0.0011% mcap 100.0% of flow Class A Common Stock SEC:0001862897-26-000013:1
● Director · Executives · 25 Aug 2026
2,000 shares @ US$24.95 0.0011% mcap 100.0% of flow Common SEC144:0001950047-26-008660
● Chief Executive Officer · Executives · 15 Aug 2026
8,505 shares @ US$24.80 0.0048% mcap 6.3% of flow Class A Common Stock SEC:0001470831-26-000824:0
● President · Executives · 15 Aug 2026
4,482 shares @ US$24.80 0.0025% mcap 100.0% of flow Class A Common Stock SEC:0001470831-26-000825:0
● Chief Financial Officer · Executives · 15 Aug 2026
15,311 shares @ US$24.80 0.0086% mcap 100.0% of flow Class A Common Stock SEC:0001470831-26-000826:0
▼ Chief Accounting Officer · Executives · 13 Aug 2026
1,770 shares @ US$24.94 0.0010% mcap 19.3% of flow Class A Common Stock SEC:0001470831-26-000827:1
● Chief Accounting Officer · Executives · 15 Aug 2026
3,882 shares @ US$24.80 0.0022% mcap 42.0% of flow Class A Common Stock SEC:0001470831-26-000827:2
● Chief Accounting Officer · Executives · 13 Aug 2026
5,000 shares Class A Common Stock SEC:0001470831-26-000827:0
● Officer · Executives · 13 Aug 2026
1,770 shares @ US$24.94 0.0009% mcap 33.3% of flow Common SEC144:0001950047-26-008058
▼ Director · Executives · 7 Aug 2026
7,500 shares @ US$39.11 0.0064% mcap 23.9% of flow Class A Common Stock SEC:0001585858-26-000002:1
● Director · Executives · 7 Aug 2026
7,500 shares Class A Common Stock SEC:0001585858-26-000002:0
● Director · Executives · 7 Aug 2026
7,500 shares @ US$39.11 0.0075% mcap 100.0% of flow Common SEC144:0001950047-26-007824
▼ Chief Accounting Officer · Executives · 15 Jul 2026
1,732 shares @ US$22.02 0.0010% mcap 43.2% of flow Class A Common Stock SEC:0002111348-26-000011:1
● Chief Accounting Officer · Executives · 15 Jul 2026
4,800 shares Class A Common Stock SEC:0002111348-26-000011:0
● Officer · Executives · 15 Jul 2026
1,732 shares @ US$22.02 0.0009% mcap 43.5% of flow Common SEC144:0001950047-26-007089
◆ Director · Executives · 13 Jul 2026
21,314 shares 0Class A Common Stock SEC:0001594511-26-000004:0
◆ Director · Executives · 15 Nov 2025
9,750 shares 0Class A Common Stock SEC:0001594511-26-000006:0
◆ President · Executives · 15 May 2026
55,524 shares 0Class A Common Stock SEC:0001470831-26-000556:0
● Interim PAO · Executives · 8 Jun 2026
5,000 shares Class A Common Stock SEC:0001470831-26-000531:0
25 of 203 declarations
Load more (178 remaining) 关于 Doximity, Inc. Doximity, Inc.是一家总部位于美国加利福尼亚州旧金山的美国公司,在纽约证券交易所上市,股票代码为DOCS。该公司成立于2010年,为美国医疗专业人员,特别是医生,建立了领先的数字平台。从投资者的角度来看,Doximity处于医疗保健、软件和数据的交汇点,使其更像一个健康科技平台,而非传统的生物技术公司。其商业模式以经过验证的临床网络和一套旨在提高医生生产力、医疗信息获取和护理协调的数字工具为中心。
该公司的核心产品是一个以医生为中心的数字生态系统。Doximity支持同事之间的协作、获取医疗新闻和研究、职业和值班管理、简化的临床文档以及虚拟患者就诊。随着时间的推移,该平台已从专业社交扩展到工作流程自动化和临床AI工具,这些已成为产品战略中日益重要的部分,也是参与度的主要驱动力。
在竞争方面,Doximity受益于强大的现有用户基础和差异化的网络效应。该公司表示,其网络覆盖了美国85%以上的医生,涵盖所有专业和执业环境。这种规模至关重要,因为平台的价值随着采用率的提高而增加,尤其是在医疗保健领域,经过验证的身份、信任和工作流程整合至关重要。竞争对手包括医疗通信平台、医疗保健软件供应商、远程医疗提供商以及新兴的AI驱动临床参考工具。然而,Doximity根深蒂固的医生受众使其具有显著的分销优势。
其主要产品和服务包括安全的专业通信、远程医疗视频、工作流程工具和临床AI功能。一项值得注意的战略举措是收购了Pathway Medical,这是一家总部位于蒙特利尔的初创公司,专注于循证临床参考和医疗AI。该交易突显了Doximity致力于深化其临床实用性并将其产品套件扩展到社交之外的努力。
从地理上看,该业务高度集中在美国,这是该公司的主要市场,也是其用户基础和货币化的核心来源。尽管Doximity可能通过收购或合作利用国际能力,但其商业重点显然在国内。最近的发展是积极的:在2026年5月发布的2026财年业绩中,该公司报告了收入增长、强劲的现金生成以及其工作流程和AI工具的创纪录使用量。管理层还强调了旨在将临床AI引入基于价值的护理环境的新合作伙伴关系,这进一步强化了Doximity正在将自己定位为美国医疗专业人员的关键任务软件层的观点。